Effectiveness of the Petö Method on Gross Motor Function in Children With Cerebral Palsy: a Quasi… (NCT07485894) | Clinical Trial Compass
CompletedNot Applicable
Effectiveness of the Petö Method on Gross Motor Function in Children With Cerebral Palsy: a Quasi-experimental Pilot Study.
Spain13 participantsStarted 2018-03-01
Plain-language summary
Cerebral palsy is the most frequent cause of physical disability in childhood. The Petö Method proposes a comprehensive pedagogical-therapeutic approach to improve functionality. Historically, the Petö Method (Conductive Education) has faced skepticism regarding its clinical efficacy. Notable reports, such as the one by the American Academy for Cerebral Palsy and Developmental Medicine (AACPDM), have previously concluded that there was insufficient evidence to support its use. However, these critiques emphasized that prior studies suffered from serious methodological deficiencies and a lack of validated measurement instruments.
Our study directly addresses these gaps by implementing the Gross Motor Function Measure-66 (GMFM-66). Unlike older scales, the GMFM-66 provides a valid and reliable estimate of motor behavior in children with CP, offering the sensitivity required to detect minimal yet clinically relevant changes.
In our results, the Petö Method is shown to be an effective intervention for improving gross motor function in children with significant levels of motor impairment. The observed changes are not only statistically significant but also clinically relevant, exceeding the minimal detectable change and promoting functional autonomy in activities of daily living.
Who can participate
Age range
4 Years – 9 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age between 4 and 9 years (inclusive)
* Diagnosis of spastic cerebral palsy, with motor impairment of level III and IV (Gross Motor Function Classification System - GMFCS)
* Sufficient cognitive competence to understand and execute simple commands. - - To have completed a three-month therapeutic rest period without any other type of prior therapy (to ensure the 'novelty' effect of the therapy and avoid contamination with other interventions).
Exclusion Criteria:
* The presence of severe sensory deficits and serious behavioral disorders that could interfere with the group dynamics of the intervention.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.